![]() |
Preoperative lapatinib plus trastuzumab elicits response in HER2-positive breast canc
Addition of lapatinib to trastuzumab improves responses in women with newly diagnosed, HER2-positive breast cancer who receive the combination prior to undergoing surgery, suggests research.
More... |
| All times are GMT -7. The time now is 10:57 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021